Has Thy Huynh received payments from drug or device companies?

Yes. Drug and device makers reported $50,690 in general payments to Thy Huynh across 154 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thy Huynh did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thy Huynh come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thy Huynh

Dermatology · Jackson, MSNPI 1043745243

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (56.6%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Incyte Corporation at 34.6% of the total. 2025 is the largest year on record at $20,077, more than ten times the $662 reported in 2019. Among dermatology clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$50,690in general payments, 2019–2025

Across 154 payments — averaging $329.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Incyte Corporation$18K
Sanofi$17K
Pfizer$5K
Arcutis Biotherapeutics, Inc.$3K
Regeneron Healthcare Solutions, Inc.$2K
Botanix SB Inc$2K
plus $4K from 12 others

$116,448in research payments, 2019–2025

Across 30 payments — averaging $3881.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Argenx US, Inc.$68K
Novartis$41K
Sanofi US Services Inc.$7K

What the payments were for

Consulting fees$28,66957%
Speaking & faculty fees$11,09722%
Travel & lodging$4,2798%
Food & beverage$6,63013%
Education$160%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Incyte Corporation	34	$17,520
Sanofi	35	$16,952
Pfizer	10	$4,592
Arcutis Biotherapeutics, Inc.	7	$2,889
Regeneron Healthcare Solutions, Inc.	10	$2,351
Botanix SB Inc	1	$2,200
Novartis	17	$1,983
AbbVie(2 entities)	11	$562
Johnson & Johnson	4	$418
Lilly USA, LLC	6	$276
Galderma Laboratories, L.p.	4	$202
Organon	5	$173
Pierre Fabre Pharmaceuticals, Inc.	2	$161
Amgen	3	$143
Kyowa Kirin, Inc.	1	$123
Janssen Scientific Affairs, LLC	1	$65
Krystal Biotech Inc	2	$47
Mallinckrodt Hospital Products Inc.	1	$35

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

OPZELURA$16,790
DUPIXENT$12,356
ZORYVE$2,699
LITFULO$2,520
SOFDRA$2,200
CIBINQO$1,890
Tremfya$280
COSENTYX$219
HEMANGEOL$140
POTELIGEO$123
STELARA$117
VTAMA$116
OLUMIANT$116
Humira$110
Rhapsido$109
Skyrizi$107
Enbrel$101

How this compares

$50,690 in reported general payments places this provider in the 90th percentile of 78 dermatology providers in Mississippi.

See all dermatology providers in Mississippi →

Medicare billing

Part B allowed, 2024

$12,892

Medicare patients

Services billed

226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Humira(Cf) PenAdalimumab	25	$335,083
CiclopiroxCiclopirox Olamine	33	$1,365
Ketoconazole	39	$658
Triamcinolone Acetonide	30	$538
Clindamycin Phosphate	12	$446
Mupirocin	17	$145

Paid to pharmacies, not to this prescriber.

Other dermatology in Jackson

Jeremy JacksonJackson$450K
Robert BrodellJackson$26K
Colleen PowersJackson$10K
Ashton DavisJackson$10K
Carlton DanielJackson$10K
Caitlyn ReedJackson$6K
Ashley EmersonJackson$6K
Summer MorrissetteJackson$4K
Sarah FillingimJackson$2K
Julie WyattJackson$2K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →